Dashboard
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of 17.37% and Operating profit at 1.04% over the last 5 years
3
Positive results in Sep 25
4
Risky -
5
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Media & Entertainment
CNY 1,773 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.12
-7.46%
1.72
Revenue and Profits:
Net Sales:
88 Million
(Quarterly Results - Sep 2025)
Net Profit:
-4 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-27.36%
0%
-27.36%
6 Months
-37.67%
0%
-37.67%
1 Year
-28.83%
0%
-28.83%
2 Years
-42.55%
0%
-42.55%
3 Years
-66.81%
0%
-66.81%
4 Years
-78.58%
0%
-78.58%
5 Years
-46.8%
0%
-46.8%
Qinghai Spring Medicinal Resources Technology Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.37%
EBIT Growth (5y)
1.04%
EBIT to Interest (avg)
-164.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.21
Tax Ratio
5.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.79
EV to EBIT
-25.08
EV to EBITDA
-36.00
EV to Capital Employed
3.06
EV to Sales
10.95
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-12.19%
ROE (Latest)
-10.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
87.70
41.30
112.35%
Operating Profit (PBDIT) excl Other Income
-3.20
4.80
-166.67%
Interest
0.00
0.10
-100.00%
Exceptional Items
-0.00
0.00
Consolidate Net Profit
-3.90
-6.20
37.10%
Operating Profit Margin (Excl OI)
-36.50%
-75.10%
3.86%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 112.35% vs -50.60% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 37.10% vs -168.89% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
265.40
213.80
24.13%
Operating Profit (PBDIT) excl Other Income
-121.80
-90.30
-34.88%
Interest
1.00
1.00
Exceptional Items
-44.80
-23.00
-94.78%
Consolidate Net Profit
-197.30
-266.20
25.88%
Operating Profit Margin (Excl OI)
-585.50%
-561.80%
-2.37%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 24.13% vs 33.54% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 25.88% vs 7.44% in Dec 2023
About Qinghai Spring Medicinal Resources Technology Co. Ltd. 
Qinghai Spring Medicinal Resources Technology Co. Ltd.
Media & Entertainment
No Details Available.
Company Coordinates 
No Company Details Available






